RactigenLogo.png
Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
06 déc. 2023 07h00 HE | Ractigen Therapeutics
This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
Global Gene Therapy Market
Global Gene Therapy Research Report 2023-2028: Increasing Regulatory Approvals, Growing Investments, Rising Demand for Cell & Gene Therapies
17 nov. 2023 09h13 HE | Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area...
RactigenLogo.png
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
02 nov. 2023 08h00 HE | Ractigen Therapeutics
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
Gene Therapy Market
Global Gene Therapy Market Poised for Remarkable 9.26% CAGR, Expected to Reach USD 10.13 Billion by 2028
31 oct. 2023 08h48 HE | Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
22157.jpg
DNA Encoded Library Market Set to Reach $840 Million in 2023, Driven by Transformative Impact on Drug Discovery
17 oct. 2023 07h53 HE | Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Advancing Beyond Antibody Drug Conjugates: Next Generation Drug Conjugates Emerge as Clinical Efficacy and Stability Game Changers
12 oct. 2023 05h38 HE | Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target...
22157.jpg
Global Oligonucleotide Synthesis Markets Research Report 2023 With Executive and Consultant Guides & Forecasts to 20277
05 oct. 2023 06h38 HE | Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
22157.jpg
Government Funding Propels Global Synthetic Biology Market, Valued at $11.24 Billion in 2022
05 oct. 2023 04h18 HE | Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market by Product, Application, Technology, End User, and by Region - Global Forecast to 2023-2033" report has been added to ...
Dyadic Logo Current.jpg
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
26 sept. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS ("bYoRNA") today announced that they entered into a development and...
Global RNA Therapy Clinical Trials Market
RNA Therapy Clinical Trials Market Report 2023-2030: Strategies and Collaborations Shaping the Industry
29 août 2023 04h48 HE | Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapy Clinical Trials Market Size, Share & Trends Analysis Report, 2023-2030" report has been added to ResearchAndMarkets.com's offering. ...